AGA technical review on nonalcoholic fatty liver disease.

By A. Sanyal. Gastroenterology, 2002

1,148 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/842f02ace57d72b70f7318526ff3cc7508938524

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. Q. Anstee
2. Robert D. Goldin
3. J. Clark
4. A. Sanyal
5. S. Grundy
6. Gerald I. Shulman

In Epidemiology

1. A. Sanyal
2. J. Clark
3. E. Brunt
4. Q. Anstee
5. A. McCullough
6. Robert D. Goldin
7. D. Kleiner
8. J. Browning

In Pathology and Forensic Medicine

1. J. Clark
2. Q. Anstee
3. A. McCullough
4. Robert D. Goldin
5. A. Sanyal
6. E. Brunt
7. Y. Kawano
8. D. Cohen

Citations in the corpus

• Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research (2006, background): “…et al. 1980; Powell et al. 1990; Wanless & Lentz 1990; Ratziu et al. 2000), dyslipidaemia (Powell et al. 1990; Sanyal 2002), insulin resistance (IR) (Powell et al. 1990; Marchesini et al. 1999; Sanyal 2002) and type II (non-insulin dependent) diabetes mellitus (Powell et al. 1990; Sanyal 2002).”
• Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. (2013, background): “Although the “gold standard” for diagnosing and staging NAFLD is histology, abdominal unltrasonography allows its detection (4, 5).”
• Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study (2005, neutral): “0001 ALT (U/L)* 28 (26)a 27 (17)a 19 (14)b ".”
• Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. (2005, background): “tological examination specifically identifies NAFLD and provides additional information regarding the nature and severity of disease (4, 5, 38), studies using liver biopsy specimens are necessarily small and prone to selection bias.”
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease (2005, background): “19 Among the goals of the network were: (1) to form a database for long-term natural history observations of patients with NAFLD; (2) to collect clinical samples for metabolic, immunological, molecular, and genetic studies of NAFLD focusing on defining the etiology of this disease; and (3) to evalua”
• The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease (2006, background): “Participants who met 3 criteria of the metabolic syndrome at baseline, n (%) 27 (2) 11 (16) 0.”